Immunodermatology is a medical specialization that concentrates on diagnosing and treating skin disorders characterized by responses that influence the body’s immune system. Immunodermatology testing is essential in the diagnosis and treatment of many diseases afflicting the epithelial organs including the skin, intestines, respiratory tract, and mucous membranes. Skin fights antigens on T cells and produces various types of cytokines because the skin is the body’s first defective organ. From newborns to the elderly, skin diseases affect patients at any time, and they can be chronic or acute, genetic or conditional, and painful or painless. Numerous factors including the surge in demand for early diagnosis of skin conditions, increase in geriatric population, enhanced health insurance, and raised disposal income are linked with the expansion of immunodermatology market size.
๐๐ข๐ฌ๐ญ ๐จ๐ ๐๐๐ฒ ๐๐ฅ๐๐ฒ๐๐ซ๐ฌ :
- Novartis
- Abbvie
- Valeant Pharmaceuticals
- Bausch Health
- Glenmark Pharmaceuticals Inc.
- Astellas Pharma
- Novopharm Limited
- Aspen Pharmacare Inc.
- Prometheus Laboratories
- Taro Pharmaceuticals Inc.
๐๐จ๐ฐ๐ง๐ฅ๐จ๐๐ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ฉ๐จ๐ซ๐ญ https://www.alliedmarketresearch.com/request-sample/12961
๐๐๐ ๐
๐๐๐๐๐๐๐ ๐๐
๐๐๐ ๐๐๐๐๐
- This study presents the analytical depiction of the immunodermatology industry along with the current trends and future estimations to determine the imminent investment pockets.
- The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the immunodermatology market share.
- The current market is quantitatively analyzed from 2021 to 2030 to highlight the immunodermatology market growth scenario.
- Porterโs five forces analysis illustrates the potency of buyers & suppliers in the market.
- The report provides a detailed immunodermatology market analysis based on competitive intensity and how the competition will take shape in coming years
๐๐ผ๐๐ถ๐ฑ-๐ญ๐ต ๐ฆ๐ฐ๐ฒ๐ป๐ฎ๐ฟ๐ถ๐ผ:
Pharmaceutical and biotech companies together with governments around the globe are working to address the COVID-19 outbreak, from supporting the development of vaccines to planning for medicine supply chain challenges. Currently, around 115 vaccine candidates and 155 molecules are in the R&D pipeline. Moreover, commonly used drugs such as Hydroxychloroquine have witnessed a dramatic surge in demand for the management of COVID-19. Such high demand for these drugs has presented huge opportunities for manufacturers of COVID-19 management drugs, as many developed countries are facing shortage of these drugs. Thus, the pharmaceutical and biotechnology industry is expected to witness a significant growth in the future owing to the demand for vaccine and treatment drugs for COVID-19. This in turn is expected to have a significant impact on the immunodermatology market.
๐
๐จ๐ซ ๐๐ฎ๐ซ๐๐ก๐๐ฌ๐ ๐๐ง๐ช๐ฎ๐ข๐ซ๐ฒ https://www.alliedmarketresearch.com/purchase-enquiry/12961
In December 2020, Arcutis Biotherapeutics, Inc., a late-stage biopharmaceutical company announced that they are focusing on the development and commercialized treatments for unmet needs in immune-mediated dermatological diseases and conditions. The robust pipeline involves 4 development programs addressing 7 dermatological diseases, which includes 3 programs in Phase 2 or Phase 3 for 5 different indications.
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of โMarket Research Reportsโ and โBusiness Intelligence Solutions.โ AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
Contact:
David Correa
5933 NE Win Sivers Drive
205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com